NorthWest Biotherapeutics Inc (NWBO)

[dedugan]

Gary,
I believe it's possible that a BP could buy 120 million shares (+\- 10% of the current float) for, say, $1.2 billion and the announcement could say that price/sh represented a mutually agreed current valuation of $10/share. The announcement would also recognize that the current 75 cents per share was a manipulated price.
Assume such a deal gave the buyer some advantages it valued, such as priority access to product/process, a right of refusal to buy another 10% tranche at $20/share in 12 months, and insider knowledge of future development plans along with a board seat. BP management could go to its BOD and convince them they are buying into an oncology-market-owning technology that may be worth $50 to $100/sh in the future, so the equity bet would be a home run by itself, but the real payoff would be owning a dominant market position for possibly decades to come.
NWBO shareholders would get an immediate bump up in price and fortune. NWBO would get loads of cash on the balance sheet for future manufacturing and product development and the ability to uplist immediately. Plus, NWBO would remain independent unless and until a really big dollar deal was put on offer.
This is just a bare-bones scenario with lots of other possibilities that would benefit patients, shareholders, and potential buyers, plus be small enough in size to be easily and quickly doable.
I've been involved in a few dozen deals, both public and private, where starting with small equity steps is the only risk-acceptable way to eventually get to the big deal that both (or multiple) parties can envision.